Table of Contents
Where is Abraxane manufactured?
Bristol Myers makes Abraxane for the U.S. market at a former Celgene site in Arizona, while outsourcing production for China to Fresenius Kabi, according to Wall Street analysts who follow the company. The biotech Celgene originally developed Abraxane, which is used to treat lung, breast and pancreatic cancers.
Who manufactures Abraxane?
ABRAXANE® is a registered trademark of Celgene Corporation. This site is intended for U.S. healthcare professionals only. ABRAXANE is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy.
How is Abraxane made?
In Abraxane, unlike conventional paclitaxel-containing medicines, the paclitaxel is attached to a human protein called albumin in tiny particles known as ‘nanoparticles’. This makes it easy to prepare a suspension of paclitaxel, which can be infused into a vein.
Why is there an Abraxane shortage?
Manufacturing delays have led to a shortage in abraxane, Bristol Myers Squibb says. The announcement comes on the heels of the FDA shooting down a petition to stall generic version of the drug. Five years after the petition was filed, the FDA rejected it completely in July.
Is there still a shortage of Abraxane?
The announcement of the shortage comes on the heels of the FDA denying a petition by Bristol Myers to stall generic versions of Abraxane. BMS settled with Teva’s Actavis, allowing at least one Abraxane generic to enter the market on March 31, 2022.
Who manufactures paclitaxel?
Bristol-Myers Squibb received approval from the FDA for paclitaxel to be used in the treatment of ovarian cancer in 1992, and for advanced breast cancer in 1994. Taxol® has been used to treat patients with lung, bladder, prostate, melanoma and esophageal cancer, and Kaposi’s sarcoma.
What is Abraxane mixed with?
ABRAXANE is supplied as a white to yellow, sterile, lyophilized powder for reconstitution with 20 mL of 0.9% Sodium Chloride Injection, USP prior to intravenous infusion. Each single-use vial contains 100 mg of paclitaxel and approximately 900 mg of human albumin.
When was Abraxane invented?
It was 1992. The year that the space shuttle Endeavour made a successful mission to space, when the Cold War came to an end and when a Frenchman called George Charpak took out a Nobel prize in Physics for his inventions of particle detectors.
When will Abraxane be available again?
BMS settled with Teva’s Actavis, allowing at least one Abraxane generic to enter the market on March 31, 2022.
Where is paclitaxel manufactured?
Our plant cell fermentation facility in Germany has an annual capacity of nearly 1,000 kg of crude paclitaxel. We are the only large-scale paclitaxel supplier in the world that controls the entire upstream and downstream production process internally under strict GMP conditions.
Is there a generic for Abraxane?
Abraxane is a brand-name prescription drug manufactured by Celgene Corporation. There is currently no generic alternative available.
What pharmaceutical company makes Taxol?
Paclitaxel (sold under trade name Taxol® by Bristol-Myers Squibb) is a very effective plant-derived chemotherapy drug used to treat breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumor cancers.
What is the cost of Abraxane?
The approximate retail price of Abraxane is usually around $10,342.42. Use a SingleCare Abraxane coupon to reduce the cost for Abraxane to $9,333.66.
When does Abraxane patent expire?
The patents covering ABRAXANE® brand drug in the United States include ten patents that are listed in the U.S. Orange Book. The last-to-expire patent (2024), U.S. Patent No.
What are the risks of Abraxane?
Abraxane contains albumin (human), a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries a remote risk for transmission of viral diseases. A theoretical risk for transmission of Creutzfeldt-Jakob Disease (CJD) also is considered extremely remote.
Why is Abraxane banned in China?
China’s drug regulators have suspended importation, sale and use of Bristol Myers Squibb’s Abraxane by its partner BeiGene due to manufacturing problems. (Getty Images) It’s not very often you hear about manufacturing problems at Western facilities slammed by Chinese authorities.
Is abraxanepro only for US healthcare professionals?
The information contained in this section of www.abraxanepro.com is technical in nature and is intended for US healthcare professionals only. If you are not a US healthcare professional, click “CANCEL” below to return to the patient and caregiver section of the site. Click “OK” if you are a healthcare professional.
How did BeiGene’s Abraxane deal with Celgene help the company?
The deal helped the biotech leapfrog into the commercial stage, bringing it the entire Celgene China commercial team. For 2019, BeiGene grew product revenue by 70% year over year to $222.6 million, with Abraxane generating half of that haul.